P F Bolton1, M Clifford1, C Tye1, C Maclean2, A Humphrey3, K le Maréchal1, J N P Higgins4, B G R Neville5, F Rijsdjik1, J R W Yates2. 1. MRC Centre for Social Genetic & Developmental Psychiatry & Department of Child Psychiatry,The Institute of Psychiatry,Kings College London,London,UK. 2. Department of Medical Genetics,University of Cambridge,Cambridge,UK. 3. Section of Developmental Psychiatry,University of Cambridge,Cambridge,UK. 4. Department of Radiology,Addenbrooke's Hospital,Cambridge,UK. 5. Institute of Child Health,University College London UK and National Centre for Young People with Epilepsy,Lingfield,UK.
Abstract
BACKGROUND: Tuberous sclerosis complex (TSC) is associated with intellectual disability, but the risk pathways are poorly understood. METHOD: The Tuberous Sclerosis 2000 Study is a prospective longitudinal study of the natural history of TSC. One hundred and twenty-five UK children age 0-16 years with TSC and born between January 2001 and December 2006 were studied. Intelligence was assessed using standardized measures at ≥2 years of age. The age of onset of epilepsy, the type of seizure disorder, the frequency and duration of seizures, as well as the response to treatment was assessed at interview and by review of medical records. The severity of epilepsy in the early years was estimated using the E-Chess score. Genetic studies identified the mutations and the number of cortical tubers was determined from brain scans. RESULTS: TSC2 mutations were associated with significantly higher cortical tuber count than TSC1 mutations. The extent of brain involvement, as indexed by cortical tuber count, was associated with an earlier age of onset and severity of epilepsy. In turn, the severity of epilepsy was strongly associated with the degree of intellectual impairment. Structural equation modelling supported a causal pathway from genetic abnormality to cortical tuber count to epilepsy severity to intellectual outcome. Infantile spasms and status epilepticus were important contributors to seizure severity. CONCLUSIONS: The findings support the proposition that severe, early onset epilepsy may impair intellectual development in TSC and highlight the potential importance of early, prompt and effective treatment or prevention of epilepsy in tuberous sclerosis.
BACKGROUND:Tuberous sclerosis complex (TSC) is associated with intellectual disability, but the risk pathways are poorly understood. METHOD: The Tuberous Sclerosis 2000 Study is a prospective longitudinal study of the natural history of TSC. One hundred and twenty-five UK children age 0-16 years with TSC and born between January 2001 and December 2006 were studied. Intelligence was assessed using standardized measures at ≥2 years of age. The age of onset of epilepsy, the type of seizure disorder, the frequency and duration of seizures, as well as the response to treatment was assessed at interview and by review of medical records. The severity of epilepsy in the early years was estimated using the E-Chess score. Genetic studies identified the mutations and the number of cortical tubers was determined from brain scans. RESULTS:TSC2 mutations were associated with significantly higher cortical tuber count than TSC1 mutations. The extent of brain involvement, as indexed by cortical tuber count, was associated with an earlier age of onset and severity of epilepsy. In turn, the severity of epilepsy was strongly associated with the degree of intellectual impairment. Structural equation modelling supported a causal pathway from genetic abnormality to cortical tuber count to epilepsy severity to intellectual outcome. Infantile spasms and status epilepticus were important contributors to seizure severity. CONCLUSIONS: The findings support the proposition that severe, early onset epilepsy may impair intellectual development in TSC and highlight the potential importance of early, prompt and effective treatment or prevention of epilepsy in tuberous sclerosis.
Authors: Petrus J de Vries; Lucy Wilde; Magdalena C de Vries; Romina Moavero; Deborah A Pearson; Paolo Curatolo Journal: Am J Med Genet C Semin Med Genet Date: 2018-08-16 Impact factor: 3.908
Authors: Iris E Overwater; Rob Swenker; Emma L van der Ende; Kimberley Bm Hanemaayer; Marianne Hoogeveen-Westerveld; Agnies M van Eeghen; Maarten H Lequin; Ans Mw van den Ouweland; Henriëtte A Moll; Mark Nellist; Marie-Claire Y de Wit Journal: Eur J Hum Genet Date: 2016-07-13 Impact factor: 4.246
Authors: Anita K Chisholm; Vicki A Anderson; Natalie A Pride; Stephanie Malarbi; Kathryn N North; Jonathan M Payne Journal: Neuropsychol Rev Date: 2018-08-11 Impact factor: 7.444
Authors: Jamie K Capal; Beatriz Bernardino-Cuesta; Paul S Horn; Donna Murray; Anna Weber Byars; Nicole M Bing; Bridget Kent; Deborah A Pearson; Mustafa Sahin; Darcy A Krueger Journal: Epilepsy Behav Date: 2017-04-28 Impact factor: 2.937
Authors: Peter E Davis; Rajna Filip-Dhima; Georgios Sideridis; Jurriaan M Peters; Kit Sing Au; Hope Northrup; E Martina Bebin; Joyce Y Wu; Darcy Krueger; Mustafa Sahin Journal: Pediatrics Date: 2017-11-03 Impact factor: 7.124
Authors: Alexander L Cohen; Brechtje P F Mulder; Anna K Prohl; Louis Soussand; Peter Davis; Mallory R Kroeck; Peter McManus; Ali Gholipour; Benoit Scherrer; E Martina Bebin; Joyce Y Wu; Hope Northrup; Darcy A Krueger; Mustafa Sahin; Simon K Warfield; Michael D Fox; Jurriaan M Peters Journal: Ann Neurol Date: 2021-01-21 Impact factor: 10.422
Authors: Jamie K Capal; Paul S Horn; Donna S Murray; Anna Weber Byars; Nicole M Bing; Bridget Kent; Lindsey A Bucher; Marian E Williams; Sarah O'Kelley; Deborah A Pearson; Mustafa Sahin; Darcy A Krueger Journal: Pediatr Neurol Date: 2017-06-27 Impact factor: 4.210
Authors: Alexandra Schoenberger; Jamie K Capal; Annie Ondracek; Paul S Horn; Donna Murray; Anna Weber Byars; Deborah A Pearson; Marian E Williams; Martina Bebin; Hope Northrup; Joyce Y Wu; Mustafa Sahin; Darcy A Krueger Journal: Epilepsy Behav Date: 2019-12-18 Impact factor: 3.337